126 related articles for article (PubMed ID: 28974363)
1. Aging dependent effect of nuclear tau.
Gil L; Federico C; Pinedo F; Bruno F; Rebolledo AB; Montoya JJ; Olazabal IM; Ferrer I; Saccone S
Brain Res; 2017 Dec; 1677():129-137. PubMed ID: 28974363
[TBL] [Abstract][Full Text] [Related]
2. Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes.
Ksiezak-Reding H; He D; Gordon-Krajcer W; Kress Y; Lee S; Dickson DW
Cell Motil Cytoskeleton; 2000 Nov; 47(3):236-52. PubMed ID: 11056524
[TBL] [Abstract][Full Text] [Related]
3. Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression.
Regalado-Reyes M; Furcila D; Hernández F; Ávila J; DeFelipe J; León-Espinosa G
J Alzheimers Dis; 2019; 69(1):277-288. PubMed ID: 30958368
[TBL] [Abstract][Full Text] [Related]
4. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.
Köhler C; Fuhr V; Dinekov M
Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467
[TBL] [Abstract][Full Text] [Related]
5. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
6. Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro.
Ksiezak-Reding H; Pyo HK; Feinstein B; Pasinetti GM
Biochim Biophys Acta; 2003 Nov; 1639(3):159-68. PubMed ID: 14636947
[TBL] [Abstract][Full Text] [Related]
7. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
[TBL] [Abstract][Full Text] [Related]
8. Perinuclear Lamin A and Nucleoplasmic Lamin B2 Characterize Two Types of Hippocampal Neurons through Alzheimer's Disease Progression.
Gil L; Niño SA; Chi-Ahumada E; Rodríguez-Leyva I; Guerrero C; Rebolledo AB; Arias JA; Jiménez-Capdeville ME
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155994
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical phosphorylation of the serine 199 on tau proteins from young individuals.
Maurage CA; Sergeant N; Ruchoux MM; Hauw JJ; Delacourte A
Neuroreport; 2001 Oct; 12(15):3177-81. PubMed ID: 11711851
[TBL] [Abstract][Full Text] [Related]
10. Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome.
Hernández-Ortega K; Garcia-Esparcia P; Gil L; Lucas JJ; Ferrer I
Brain Pathol; 2016 Sep; 26(5):593-605. PubMed ID: 26512942
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model.
Mondragón-Rodríguez S; Salas-Gallardo A; González-Pereyra P; Macías M; Ordaz B; Peña-Ortega F; Aguilar-Vázquez A; Orta-Salazar E; Díaz-Cintra S; Perry G; Williams S
J Biol Chem; 2018 Jun; 293(22):8462-8472. PubMed ID: 29632073
[TBL] [Abstract][Full Text] [Related]
12. Analysis of ribosomal protein S6 baseline phosphorylation and effect of tau pathology in the murine brain and human hippocampus.
Klingebiel M; Dinekov M; Köhler C
Brain Res; 2017 Mar; 1659():121-135. PubMed ID: 28119058
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia.
Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R
Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448
[TBL] [Abstract][Full Text] [Related]
14. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP
J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Tau and Its Potential Role in Alzheimer's Disease.
Bukar Maina M; Al-Hilaly YK; Serpell LC
Biomolecules; 2016 Jan; 6(1):9. PubMed ID: 26751496
[TBL] [Abstract][Full Text] [Related]
16. The identification of raft-derived tau-associated vesicles that are incorporated into immature tangles and paired helical filaments.
Nishikawa T; Takahashi T; Nakamori M; Hosomi N; Maruyama H; Miyazaki Y; Izumi Y; Matsumoto M
Neuropathol Appl Neurobiol; 2016 Dec; 42(7):639-653. PubMed ID: 26501932
[TBL] [Abstract][Full Text] [Related]
17. Aging and Alzheimer's disease connection: Nuclear Tau and lamin A.
Gil L; Niño SA; Capdeville G; Jiménez-Capdeville ME
Neurosci Lett; 2021 Apr; 749():135741. PubMed ID: 33610669
[TBL] [Abstract][Full Text] [Related]
18. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.
Lüth HJ; Ogunlade V; Kuhla B; Kientsch-Engel R; Stahl P; Webster J; Arendt T; Münch G
Cereb Cortex; 2005 Feb; 15(2):211-20. PubMed ID: 15238435
[TBL] [Abstract][Full Text] [Related]
19. A mouse model to study tau pathology related with tau phosphorylation and assembly.
Engel T; Lucas JJ; Hernández F; Avila J
J Neurol Sci; 2007 Jun; 257(1-2):250-4. PubMed ID: 17362999
[TBL] [Abstract][Full Text] [Related]
20. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
